Gollust Keith R
Insider CIK 1325712 · SNTA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-21 | 9,470 | — | $0 | 9,470 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2021-06-17 | 2021-06-21 | 12,489 | — | $0 | 12,489 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2020-06-17 | 2020-06-18 | 6,000 | — | $0 | 6,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2019-06-27 | 2019-07-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2018-06-19 | 2018-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2017-06-29 | 2017-06-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2016-07-22 | 2016-10-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2016-07-22 | 2016-11-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-12-14 | 2015-12-15 | 300,000 | $0.32 | $96.0K | 1,539,169 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-12-11 | 2015-12-15 | 300,000 | $0.37 | $111.0K | 1,839,169 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-12-09 | 2015-12-09 | 145,892 | $0.38 | $55.4K | 2,139,169 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-12-08 | 2015-12-09 | 300,000 | $0.38 | $114.0K | 2,285,061 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-12-07 | 2015-12-09 | 300,000 | $0.39 | $117.0K | 2,585,061 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-11-17 | 2015-11-19 | 100,000 | $0.41 | $41.0K | 2,885,061 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-11-10 | 2015-11-12 | 188,322 | $0.55 | $103.6K | 2,985,061 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | S Sale | 2015-11-10 | 2015-11-13 | 188,322 | $0.55 | $103.6K | 2,985,061 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2015-07-01 | 2015-07-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2015-07-01 | 2015-07-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2015-07-01 | 2015-07-06 | 22,727 | — | $0 | 374,493 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2015-07-01 | 2015-07-06 | 4,545 | — | $0 | 401,764 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2015-07-01 | 2015-07-06 | 4,545 | — | $0 | 397,219 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2015-07-01 | 2015-07-06 | 4,545 | — | $0 | 392,674 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2015-07-01 | 2015-07-06 | 13,636 | — | $0 | 388,129 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | P Buy | 2015-04-06 | 2015-04-08 | 350,000 | $1.75 | $612.5K | 3,173,383 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2014-07-01 | 2014-07-03 | 4,500 | — | $0 | 4,500 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2014-07-01 | 2014-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2014-07-01 | 2014-07-03 | 9,756 | — | $0 | 342,011 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2014-07-01 | 2014-07-03 | 1,219 | — | $0 | 351,766 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2014-07-01 | 2014-07-03 | 4,878 | — | $0 | 346,889 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2014-07-01 | 2014-07-03 | 2,439 | — | $0 | 349,328 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2014-07-01 | 2014-07-03 | 1,219 | — | $0 | 350,547 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | P Buy | 2013-11-13 | 2013-11-15 | 150,000 | $3.75 | $562.5K | 2,823,383 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2013-07-01 | 2013-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2013-07-01 | 2013-07-03 | 4,500 | — | $0 | 4,500 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2013-07-01 | 2013-07-03 | 8,000 | — | $0 | 324,255 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2013-07-01 | 2013-07-03 | 4,000 | — | $0 | 328,255 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2013-07-01 | 2013-07-03 | 2,000 | — | $0 | 330,255 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2013-07-01 | 2013-07-03 | 1,000 | — | $0 | 332,255 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2013-07-01 | 2013-07-03 | 1,000 | — | $0 | 331,255 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 75,000 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 5,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 2,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 5,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 2,250 | — | $0 | 2,250 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 2,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 5,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 2,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 5,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise deriv | 2013-01-23 | 2013-01-24 | 2,500 | — | $0 | 0 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 2,500 | $2.38 | $6.0K | 293,005 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 5,500 | $2.38 | $13.1K | 290,505 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 2,500 | $7.03 | $17.6K | 285,005 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 5,500 | $7.03 | $38.7K | 282,505 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 75,000 | $10.84 | $813.0K | 277,005 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 2,250 | $5.47 | $12.3K | 316,255 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 5,000 | $5.47 | $27.4K | 314,005 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 2,500 | $5.09 | $12.7K | 309,005 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 5,500 | $5.09 | $28.0K | 306,505 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 2,500 | $2.59 | $6.5K | 301,005 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | M Exercise | 2013-01-23 | 2013-01-24 | 5,500 | $2.59 | $14.2K | 298,505 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-12-12 | 2012-12-14 | 175,000 | $8.60 | $1.50M | 175,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-12-12 | 2012-12-14 | 75,000 | $8.60 | $645.0K | 2,673,383 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-07-25 | 2012-07-27 | 770,416 | $6.49 | $5.00M | 2,598,383 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2012-07-01 | 2012-07-03 | 4,500 | — | $0 | 4,500 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2012-07-01 | 2012-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-07-01 | 2012-07-03 | 914 | — | $0 | 202,005 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-07-01 | 2012-07-03 | 914 | — | $0 | 201,091 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-07-01 | 2012-07-03 | 1,828 | — | $0 | 200,177 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-07-01 | 2012-07-03 | 3,656 | — | $0 | 198,349 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2012-07-01 | 2012-07-03 | 7,312 | — | $0 | 194,693 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | P Buy | 2012-06-29 | 2012-07-02 | 150,000 | $5.35 | $802.5K | 1,827,967 | SEC↗ |